Florida
Alzheimer's disease clinical trials in Florida
61 Alzheimer's disease studies are recruiting participants at sites in 50 cities across Florida as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Florida by city
Cities with the most studies recruiting right now.
Miami
24 studies recruiting.
Tampa
20 studies recruiting.
Maitland
19 studies recruiting.
Orlando
19 studies recruiting.
Winter Park
11 studies recruiting.
Stuart
10 studies recruiting.
The Villages
10 studies recruiting.
Aventura
8 studies recruiting.
Daytona Beach
8 studies recruiting.
Wellington
8 studies recruiting.
Jacksonville
7 studies recruiting.
Lady Lake
7 studies recruiting.
Every Florida city with a recruiting study
Miami (24), Tampa (20), Maitland (19), Orlando (19), Winter Park (11), Stuart (10), The Villages (10), Aventura (8), Daytona Beach (8), Wellington (8), Jacksonville (7), Lady Lake (7), Atlantis (6), Clermont (6), Miami Lakes (6), Port Orange (6), West Palm Beach (6), Boca Raton (5), Bonita Springs (5), Doral (5), Fort Myers (5), Hialeah (5), Naples (5), Ocala (5), Delray Beach (4), Homestead (4), Melbourne (4), Sarasota (4), Bradenton (3), Merritt Island (3), Miami Gardens (3), Brandon (2), New Port Richey (2), Virginia Gardens (2), Coconut Creek (1), Coral Springs (1), Cutler Bay (1), Deerfield Beach (1), Fort Lauderdale (1), Gainesville (1), Greenacres City (1), Miami Beach (1), Miami Springs (1), Mt. Dora (1), Ocoee (1), Ormond Beach (1), Pensacola (1), Tallahassee (1), Viera (1), Weston (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Florida
Basic details from each study's public record (the 12 most recently updated of 61). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Atlantis · Clermont · Lady Lake · and 10 more U.S. locations
- Registry record
- NCT07177352 · updated
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
- Phase 2
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Stuart · Wellington · Winter Park
- Registry record
- NCT07781657 · updated
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Recruiting in
- Bonita Springs · Clermont · Cutler Bay · and 13 more U.S. locations
- Registry record
- NCT05980949 · updated
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Recruiting in
- Boca Raton · Deerfield Beach · Doral · and 7 more U.S. locations
- Registry record
- NCT06887192 · updated
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Miami · Port Orange · Tampa · and 1 more U.S. location
- Registry record
- NCT06937229 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Merritt Island · Orlando · Port Orange · and 1 more U.S. location
- Registry record
- NCT07011732 · updated
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Sanofi
- Recruiting in
- Naples · Orlando · Stuart · and 3 more U.S. locations
- Registry record
- NCT07688213 · updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Phase 3
- Ages 55 to 80
- All sexes
- Sponsor
- Hoffmann-La Roche
- Recruiting in
- Maitland · Ocala · Orlando · and 4 more U.S. locations
- Registry record
- NCT07717411 · updated
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Recruiting in
- Aventura · Daytona Beach · Doral · and 7 more U.S. locations
- Registry record
- NCT06159673 · updated
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
- Phase 1
- Ages 18 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Daytona Beach
- Registry record
- NCT07787169 · updated
Flutemetamol F 18 Injection Formulation Comparison
- Phase 2
- Ages 50 to 110
- All sexes
- Sponsor
- GE Healthcare
- Recruiting in
- Aventura · Miami · Winter Park
- Registry record
- NCT07873463 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Atlantis · Aventura · Delray Beach · and 8 more U.S. locations
- Registry record
- NCT07589595 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Florida on ClinicalTrials.gov.
Ask about studies in Florida
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections